Authors
Latest:
Supporting pharma’s shift in focus from patient 'outputs’ to ‘outcomes’The rise of the patient voice and increased acceptance of remote engagement are sparking a culture change across the supply chain
Latest:
The dynamic evolution of multi-sponsor REMSRisk Evaluation & Mitigation Strategy (REMS) programs are evolving, with new complexities for compliance managers
Latest:
The stakes are high in the debate over follow-on biologicsCould proposed legislation undercut the promise of targeted therapies?
Latest:
Biosimilars: It's a matter of timeFor global markets, there is a need to balance the imperative to get to market quickly against the evolving regulatory landscape
Latest:
Strategies for effective patient services programsAddressing continued hurdles in patient adherence
Latest:
The power of visualization in patient educationVisual aids, diminished for a time as a marketing and educational tool because of industry restrictions, are making a comeback
Latest:
Artificial Intelligence: Beyond the glamorIt takes gritty work to make an AI application succeed—but it can be worth the effort
Latest:
Coverage -- Access: Pharma Must Play Activist Role in Health Reform EffortsPrivate and public sectors can collaborate to achieve meaningful reform
Latest:
Biopharma Sales and Marketing Process Changes Are Failing to Keep up With Industry EvolutionBetter internal collaboration within companies is critical to improving the vital physician-rep relationship
Latest:
Rare disease patient supportRare diseases are hard to treat; supporting the patient can be even more challenging
Latest:
Extend Sampling Programs With Telemarketing and Direct MailA biopharma marketer uses direct mail and a call center to access hard-to-reach physicians
Latest:
Biopharma cold-chain market forecastMore biologic-based therapies translates into more cold chain activity. As yet, new cellular and genetic therapies are a minute part of the overall market.
Latest:
A case study in differing approaches to reimbursement approval in Europe and the USLooking at 'cost' and 'value' under different evaluation processes
Latest:
Recent US Supreme Court decisions narrow life-sciences patentability claimsIndustry response may be to keep more innovations as trade secrets
Latest:
Six Steps to Driving Patient Support Program EnrollmentAlthough there is no ‘one size fits all’ solution, the process is influenced by factors such as lifestyle stage, competitive outlook, and market constraints.
Latest:
Optimizing hub services with the power of cloud and mobileCloud-based IT technologies are a natural fit for patient-support hubs
Latest:
Key Elements for Success in Pharma M&A IntegrationHow can buyers maximize the value of their acquisitions?
Latest:
GS1 standards are vital for pharma serialization‘Future proof’ your implementation by adhering to industry standards
Latest:
Online personal data will be a boon for patient supportSpecialty-pharma support providers have a potential benefit in behavioral targeting insights
Latest:
First physicians, now patients: Risk avoidance in patient support programsA look into the growing compliance risks associated with patient services
Latest:
Pragmatic randomized clinical trials: Real-world evidence made for payers and regulatorsA complement to the classic randomized clinical trial may benefit drug commercialization
Latest:
The Battle for Control of Specialty DrugsSpecialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement
Latest:
Analyzing drug-pricing mechanismsPricing systems in US drug supply chain have many limitations; an analytics-based method might avoid some of them
Latest:
Generic Manufacturers Gain Another Advantage in Disputing Drug PatentsFDA sets a precedent for granting generic approvals even when initial litigation goes against the generic manufacturer
Latest:
Make your CRM vendor a true partner to your sales teamToday's cloud-based, fast-evolving CRM systems call for a closer partnership between vendor and client
